GBLD vs. OZEM ETF Comparison

Comparison of Invesco MSCI Green Building ETF (GBLD) to Roundhill GLP-1 & Weight Loss ETF (OZEM)

GBLD

Invesco MSCI Green Building ETF

GBLD Description

Invesco Exchange-Traded Fund Trust II - Invesco MSCI Green Building ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of companies operating across diversified market capitalization. The fund invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. It seeks to track the performance of the MSCI Global Green Building Index, by using full replication technique. The fund does not invest in stocks of companies operating across controversial weapons sector. Invesco Exchange-Traded Fund Trust II - Invesco MSCI Green Building ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$16.99

Average Daily Volume

8,159

Number of Holdings ^*

* may have additional holdings in another (foreign) market

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$25.91

Average Daily Volume

37,536

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	GBLD	OZEM
30 Days	-3.79%	-7.33%
60 Days	-8.26%	-7.73%
90 Days	-5.07%	-10.10%
12 Months	10.48%

0 Overlapping Holdings

	Symbol	Grade	Weight in GBLD	Weight in OZEM	Overlap

GBLD Overweight 19 Positions Relative to OZEM

Symbol	Grade	Weight
ARE	D	6.6%
BXP	D	4.55%
VNO	B	2.62%
MTH	D	2.48%
KBH	D	2.28%
SLG	B	1.9%
CUZ	B	1.8%
KRC	C	1.71%
HIW	D	1.31%
DEI	B	1.16%
EQC	B	0.9%
ESRT	C	0.57%
AAT	B	0.51%
JBGS	D	0.5%
PDM	D	0.45%
BZH	B	0.37%
PGRE	F	0.34%
BDN	C	0.33%
HPP	F	0.2%

GBLD Underweight 14 Positions Relative to OZEM

Symbol	Grade	Weight
NVO	D	-17.04%
LLY	F	-14.13%
ALT	C	-4.44%
AZN	D	-3.99%
VKTX	F	-3.39%
AMGN	D	-3.26%
PFE	D	-3.07%
SRRK	B	-2.8%
REGN	F	-2.4%
RYTM	C	-2.3%
TAK	F	-2.17%
TERN	F	-1.97%
CORT	B	-1.77%
OPK	C	-1.72%

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic